SlideShare a Scribd company logo
1 of 23
Screening of drugs used for
contraception
PRESENTER : DR MOHAMED AJEEM
MODERATOR : DR PRAMOD
Contents
 Introduction
 Mechanism
 Types
 Anti ovulatory activity
 Estrogenic activity
 Progestional activity
 Anti-implantation activity
 Androgenic activity
 Conclusion
INTRODUCTION
 Contraception: Interception of birth process at any stage ranging from
ovulation to ovum implantation
 Anti fertility agents are substances which prevents reproduction by
interfering with normal reproductive agents in both male and female
Contraceptives currently in use
 Estrogens
 Natural: Estradiol, Estriol and
Estrone
 Synthetic: Ethinyl-estradiol,
Mestranol
 Progestins
 Natural: Progesterone, 17 α
hydroxyprogesterone
 Synthetic: Levonorgestrel,
Desogestrel,
Medroxyprogesterone acetate
Mechanism of Anti-fertility
 Inhibition of ovulation.
 Prevention of fertilization.
 Interference with transport of ova from oviduct to endometrium of the
uterus.
 Interference with the implantation of fertilized ovum.
 Distraction of early implanted embryo.
Screening methods (Female)
Anti Ovulatory
 HCG induced ovulation in
rats
 Cupric acetate induced
ovulation in rabbits
Estrogenic
 Vaginal Opening
 Vaginal Cornification
 Uterine weight assay
 Chick oviduct method
Progestional
 Pregnancy maintenance
test
 Clauberg Mcphail test
 Endometrial carbonic
anhydrase
Screening methods(male)
 Chicken comb method
 Weight of ventral prostate, seminal vesicles
and musculus levator ani
Anti-ovulatory Activity
Female albino rats
24-26 days old
treated with Test
dose followed by
HCG
After 2 days,
animals are
sacrificed, ovaries
are dissected out
preserved in 10%
buffered formalin
and subjected to
histopathological
evaluation
HCG induced ovulation in rats
Principle: Human chorionic gonadotropin (HCG) induces follicle maturation,
followed by spontaneous ovulation 2 days later
Anti-ovulatory Activity
Cupric acetate-induced ovulation in rabbits
Principle : rabbits ovulates within a few hours after an i.v.
injection of cupric acetate (0.3 mg/ kg using 1% cupric acetate
in 0.9% saline). Injection of anti-ovulatory drugs, 24 h before
the induction procedure prevents ovulation.
Anti-ovulatory Activity
 Procedure:
 Sexually mature female albino rabbits, weighing 3–4 kg
 Animals kept in isolation for at least 21 days
 Test drug, and 24 h later an i.v. injection of cupric acetate is given.
 The rabbits are sacrificed and the ovaries are examined 18–24 h later.
 The total number of ovulation points
Vaginal Cornification (Estrogenic Activity)
 Rats and mice exhibit cyclic ovulation and associated changes in hormones
 Adult female albino rats are used for the study
 Changes in vagina is observed by taking vaginal smears examining for
cornified cells, leucocytes and epithelial cells
 Any drug which changes animals to estrus stage is considered to have
estrogenic activity
Seven-day old pullet
chicks are injected s.c
twice daily with test
compound in various
doses X 6 days
Standard doses
estradiol-17β
between 0.02
and 0.5 μg
Animals are
sacrificed and
weight of the
body and oviduct
determined
 Chick Oviduct Method:
 principle: The weight of the oviduct of
young chicken is increased dose-
dependently by natural and synthetic
estrogens
Uterine weight assay
Principle: Repeated administration of
estrogens induces a dose-dependent increase
of uterine weight in castrated female rats.
Immature female
Sprague-Dawley
rats (55 g) are
ovariectomized
Test compound -
Orally or S.C in 0.5%
Solution of
carboxymethylcellulose
or in cotton seed
Oil
On the 8th day,
the animals are
sacrificed and
uterine weights
determined
Clauberg (McPhail) test in rabbits
(Progestional activity)
Immature female rabbits (weighing 550–650 g) receive daily
injections of 5.0 μg estradiol benzoate for 6 days
7th -12th day the rabbits are administered the test
drug or the standard (0.02, 0.08 and 2.0 mg
progesterone) s.c
15th day, animals are sacrificed, uterus removed and fixed
in 10% formalin. Sections are made from the middle part
of each horn for histological examination
Clauberg (McPhail) test in rabbits
(Progestional activity)
Pregnancy maintenance test (progestional)
Day 1
• Mature Sprague-
Dawley female
rats inseminated
by being placed
with males
overnight
8-13 days
• ovariectomized if
found pregnant
and test
compounds are
administered once
daily, s.c
21 th day
• Animals are
sacrificed and
presence or
absence of
implantation sites
are noted
Anti-implantation Activity
 Female albino in proestrous or estrous stage are mated with matured male rats (female 3:1
male)
 examined for the presence of spermatozoa in the early morning vaginal smear
 Drug is administered orally to the animals once daily
 10th of pregnancy, the animals are laparotomized ; number of implants present in both the
uterine horns each ovary is counted. The animals are allowed to complete the gestation period
(21-23 days) and the number of litters delivered
Animals are divided in
to group of 8 animals
Surface area of
Individual comb is
measured
The capons
are injected daily i.m
for 5 consecutive
days test compound
or the standard in 1 ml
olive oil
Surface area of
Individual comb is
remeasured 24 hrs
after the last injection
Chicken comb method
(Androgenic activity)
Weight of ventral prostate, seminal vesicles
and musculus levator ani
 Principle: In the rat, the growth of the ventral prostate, the seminal vesicles and the
musculus levator ani is dependent on the presence of male sexual hormones. Weight
increase of the musculus levator ani is considered to indicate anabolic activity
 Immature male Sprague-Dawley rats weighing about 55 g are orchidectomized
 Test compound is administered in various doses administered orally or s.c for 10 days
Weight of ventral prostate, seminal vesicles
and musculus levator ani
 Standard- Testosterone (0.02, 0.1, and 0.5 mg) s.c or methyltestosterone (0.25, 1.5, and
5 mg)
 Ten animals are used for each group.
 On the 11th day, the animals are sacrificed and the seminal vesicles, the ventral
prostate, and the musculus levator ani are dissected and weighed
 Dose-response curves are constructed for each organ comparing the test compound
with the standard in order to calculate potency ratios
Conclusion
 An ideal contraceptive agent must possess 100% efficacy, Reversibility of action and free
from adverse events and easy to use
 Newer methods are needed to support the reproductive health needs of both women and
men, recognizing that these needs may change over their reproductive life-course.
 Methods under development aim to reduce potential side effects, improve access and
ease of use, ensure safety, increase secondary benefit associated with method use.
References
 Vogel HG. Drug discovery and evaluation: pharmacological assays. 4th ed. New York: Springer;
2016.
 Gupta SK. Drug screening methods. 3rd ed. New Delhi: Jaypee; 2016
 Shah M, Singh R, Shah R, Kakar S. An overview of the current methodologies used for evaluation of
anti-fertility agents. Asian Pac J Reprod. 2016;5:175–8
 Gnanasegaran, S., Adhimoolam, M. (2022). Screening Methods for the Evaluation of Antifertility
Drugs. In: Lakshmanan, M., Shewade, D.G., Raj, G.M. (eds) Introduction to Basics of Pharmacology
and Toxicology. Springer, Singapore.
 Haddad LB, Townsend JW, Sitruk-Ware R. Contraceptive Technologies: Looking Ahead to New
Approaches to Increase Options for Family Planning. Clin Obstet Gynecol. 2021 Sep 1;64(3):435-
448.

More Related Content

Similar to Screening of anti-fertility agents.powerpointt

In vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityIn vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityswapniltirmanwar
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agentJaineel Dharod
 
screening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxscreening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxPraveen kumar S
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicologyAanchal46
 
Reproductive toxicology studies
Reproductive toxicology studiesReproductive toxicology studies
Reproductive toxicology studieskusuma khushi
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptxashharnomani
 
Female reproductive toxicity studies.pptx
Female reproductive toxicity studies.pptxFemale reproductive toxicity studies.pptx
Female reproductive toxicity studies.pptxashharnomani
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Teratogenicity studies
Teratogenicity studiesTeratogenicity studies
Teratogenicity studiesRajesh Yadav
 
Assignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesAssignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesDeepak Kumar
 
Similar endometrial development
Similar endometrial developmentSimilar endometrial development
Similar endometrial developmentt7260678
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelinesR Nadaf
 
ARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUEARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUETripti Sidar
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology Naveen K L
 

Similar to Screening of anti-fertility agents.powerpointt (20)

In vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityIn vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activity
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
 
Ppt on antifertility
Ppt on antifertilityPpt on antifertility
Ppt on antifertility
 
screening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxscreening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptx
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
 
DOC-20220404-WA0001..pptx
DOC-20220404-WA0001..pptxDOC-20220404-WA0001..pptx
DOC-20220404-WA0001..pptx
 
Reproductive toxicology studies
Reproductive toxicology studiesReproductive toxicology studies
Reproductive toxicology studies
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
Female reproductive toxicity studies.pptx
Female reproductive toxicity studies.pptxFemale reproductive toxicity studies.pptx
Female reproductive toxicity studies.pptx
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Reproductive toxicity studies
Reproductive toxicity studiesReproductive toxicity studies
Reproductive toxicity studies
 
thesis seminar
 thesis seminar thesis seminar
thesis seminar
 
Teratogenicity studies
Teratogenicity studiesTeratogenicity studies
Teratogenicity studies
 
F0351033038
F0351033038F0351033038
F0351033038
 
Assignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesAssignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studies
 
Similar endometrial development
Similar endometrial developmentSimilar endometrial development
Similar endometrial development
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelines
 
ARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUEARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUE
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology
 
SUB ACUTE ORAL TOXICITY
SUB ACUTE ORAL TOXICITYSUB ACUTE ORAL TOXICITY
SUB ACUTE ORAL TOXICITY
 

More from sujitha12341

SCREENING OF DIURETICS_075702.pptx presentation
SCREENING OF DIURETICS_075702.pptx presentationSCREENING OF DIURETICS_075702.pptx presentation
SCREENING OF DIURETICS_075702.pptx presentationsujitha12341
 
STROBE-IS2012.ppt check list presentation
STROBE-IS2012.ppt check list presentationSTROBE-IS2012.ppt check list presentation
STROBE-IS2012.ppt check list presentationsujitha12341
 
Pharmacological Management of Post-Herpetic Neuralgia.pptx
Pharmacological Management of Post-Herpetic Neuralgia.pptxPharmacological Management of Post-Herpetic Neuralgia.pptx
Pharmacological Management of Post-Herpetic Neuralgia.pptxsujitha12341
 
drug delivery system seminar pharmacology
drug delivery system seminar pharmacologydrug delivery system seminar pharmacology
drug delivery system seminar pharmacologysujitha12341
 
Adrenergic antagonists in pharmacology.ppt
Adrenergic antagonists in pharmacology.pptAdrenergic antagonists in pharmacology.ppt
Adrenergic antagonists in pharmacology.pptsujitha12341
 
drug delivery system seminar pharmacology
drug delivery system seminar pharmacologydrug delivery system seminar pharmacology
drug delivery system seminar pharmacologysujitha12341
 

More from sujitha12341 (6)

SCREENING OF DIURETICS_075702.pptx presentation
SCREENING OF DIURETICS_075702.pptx presentationSCREENING OF DIURETICS_075702.pptx presentation
SCREENING OF DIURETICS_075702.pptx presentation
 
STROBE-IS2012.ppt check list presentation
STROBE-IS2012.ppt check list presentationSTROBE-IS2012.ppt check list presentation
STROBE-IS2012.ppt check list presentation
 
Pharmacological Management of Post-Herpetic Neuralgia.pptx
Pharmacological Management of Post-Herpetic Neuralgia.pptxPharmacological Management of Post-Herpetic Neuralgia.pptx
Pharmacological Management of Post-Herpetic Neuralgia.pptx
 
drug delivery system seminar pharmacology
drug delivery system seminar pharmacologydrug delivery system seminar pharmacology
drug delivery system seminar pharmacology
 
Adrenergic antagonists in pharmacology.ppt
Adrenergic antagonists in pharmacology.pptAdrenergic antagonists in pharmacology.ppt
Adrenergic antagonists in pharmacology.ppt
 
drug delivery system seminar pharmacology
drug delivery system seminar pharmacologydrug delivery system seminar pharmacology
drug delivery system seminar pharmacology
 

Recently uploaded

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 

Recently uploaded (20)

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 

Screening of anti-fertility agents.powerpointt

  • 1. Screening of drugs used for contraception PRESENTER : DR MOHAMED AJEEM MODERATOR : DR PRAMOD
  • 2. Contents  Introduction  Mechanism  Types  Anti ovulatory activity  Estrogenic activity  Progestional activity  Anti-implantation activity  Androgenic activity  Conclusion
  • 3. INTRODUCTION  Contraception: Interception of birth process at any stage ranging from ovulation to ovum implantation  Anti fertility agents are substances which prevents reproduction by interfering with normal reproductive agents in both male and female
  • 4. Contraceptives currently in use  Estrogens  Natural: Estradiol, Estriol and Estrone  Synthetic: Ethinyl-estradiol, Mestranol  Progestins  Natural: Progesterone, 17 α hydroxyprogesterone  Synthetic: Levonorgestrel, Desogestrel, Medroxyprogesterone acetate
  • 5. Mechanism of Anti-fertility  Inhibition of ovulation.  Prevention of fertilization.  Interference with transport of ova from oviduct to endometrium of the uterus.  Interference with the implantation of fertilized ovum.  Distraction of early implanted embryo.
  • 6. Screening methods (Female) Anti Ovulatory  HCG induced ovulation in rats  Cupric acetate induced ovulation in rabbits Estrogenic  Vaginal Opening  Vaginal Cornification  Uterine weight assay  Chick oviduct method Progestional  Pregnancy maintenance test  Clauberg Mcphail test  Endometrial carbonic anhydrase
  • 7. Screening methods(male)  Chicken comb method  Weight of ventral prostate, seminal vesicles and musculus levator ani
  • 8. Anti-ovulatory Activity Female albino rats 24-26 days old treated with Test dose followed by HCG After 2 days, animals are sacrificed, ovaries are dissected out preserved in 10% buffered formalin and subjected to histopathological evaluation HCG induced ovulation in rats Principle: Human chorionic gonadotropin (HCG) induces follicle maturation, followed by spontaneous ovulation 2 days later
  • 9. Anti-ovulatory Activity Cupric acetate-induced ovulation in rabbits Principle : rabbits ovulates within a few hours after an i.v. injection of cupric acetate (0.3 mg/ kg using 1% cupric acetate in 0.9% saline). Injection of anti-ovulatory drugs, 24 h before the induction procedure prevents ovulation.
  • 10. Anti-ovulatory Activity  Procedure:  Sexually mature female albino rabbits, weighing 3–4 kg  Animals kept in isolation for at least 21 days  Test drug, and 24 h later an i.v. injection of cupric acetate is given.  The rabbits are sacrificed and the ovaries are examined 18–24 h later.  The total number of ovulation points
  • 11. Vaginal Cornification (Estrogenic Activity)  Rats and mice exhibit cyclic ovulation and associated changes in hormones  Adult female albino rats are used for the study  Changes in vagina is observed by taking vaginal smears examining for cornified cells, leucocytes and epithelial cells  Any drug which changes animals to estrus stage is considered to have estrogenic activity
  • 12. Seven-day old pullet chicks are injected s.c twice daily with test compound in various doses X 6 days Standard doses estradiol-17β between 0.02 and 0.5 μg Animals are sacrificed and weight of the body and oviduct determined  Chick Oviduct Method:  principle: The weight of the oviduct of young chicken is increased dose- dependently by natural and synthetic estrogens
  • 13. Uterine weight assay Principle: Repeated administration of estrogens induces a dose-dependent increase of uterine weight in castrated female rats. Immature female Sprague-Dawley rats (55 g) are ovariectomized Test compound - Orally or S.C in 0.5% Solution of carboxymethylcellulose or in cotton seed Oil On the 8th day, the animals are sacrificed and uterine weights determined
  • 14. Clauberg (McPhail) test in rabbits (Progestional activity) Immature female rabbits (weighing 550–650 g) receive daily injections of 5.0 μg estradiol benzoate for 6 days 7th -12th day the rabbits are administered the test drug or the standard (0.02, 0.08 and 2.0 mg progesterone) s.c 15th day, animals are sacrificed, uterus removed and fixed in 10% formalin. Sections are made from the middle part of each horn for histological examination
  • 15. Clauberg (McPhail) test in rabbits (Progestional activity)
  • 16. Pregnancy maintenance test (progestional) Day 1 • Mature Sprague- Dawley female rats inseminated by being placed with males overnight 8-13 days • ovariectomized if found pregnant and test compounds are administered once daily, s.c 21 th day • Animals are sacrificed and presence or absence of implantation sites are noted
  • 17. Anti-implantation Activity  Female albino in proestrous or estrous stage are mated with matured male rats (female 3:1 male)  examined for the presence of spermatozoa in the early morning vaginal smear  Drug is administered orally to the animals once daily  10th of pregnancy, the animals are laparotomized ; number of implants present in both the uterine horns each ovary is counted. The animals are allowed to complete the gestation period (21-23 days) and the number of litters delivered
  • 18.
  • 19. Animals are divided in to group of 8 animals Surface area of Individual comb is measured The capons are injected daily i.m for 5 consecutive days test compound or the standard in 1 ml olive oil Surface area of Individual comb is remeasured 24 hrs after the last injection Chicken comb method (Androgenic activity)
  • 20. Weight of ventral prostate, seminal vesicles and musculus levator ani  Principle: In the rat, the growth of the ventral prostate, the seminal vesicles and the musculus levator ani is dependent on the presence of male sexual hormones. Weight increase of the musculus levator ani is considered to indicate anabolic activity  Immature male Sprague-Dawley rats weighing about 55 g are orchidectomized  Test compound is administered in various doses administered orally or s.c for 10 days
  • 21. Weight of ventral prostate, seminal vesicles and musculus levator ani  Standard- Testosterone (0.02, 0.1, and 0.5 mg) s.c or methyltestosterone (0.25, 1.5, and 5 mg)  Ten animals are used for each group.  On the 11th day, the animals are sacrificed and the seminal vesicles, the ventral prostate, and the musculus levator ani are dissected and weighed  Dose-response curves are constructed for each organ comparing the test compound with the standard in order to calculate potency ratios
  • 22. Conclusion  An ideal contraceptive agent must possess 100% efficacy, Reversibility of action and free from adverse events and easy to use  Newer methods are needed to support the reproductive health needs of both women and men, recognizing that these needs may change over their reproductive life-course.  Methods under development aim to reduce potential side effects, improve access and ease of use, ensure safety, increase secondary benefit associated with method use.
  • 23. References  Vogel HG. Drug discovery and evaluation: pharmacological assays. 4th ed. New York: Springer; 2016.  Gupta SK. Drug screening methods. 3rd ed. New Delhi: Jaypee; 2016  Shah M, Singh R, Shah R, Kakar S. An overview of the current methodologies used for evaluation of anti-fertility agents. Asian Pac J Reprod. 2016;5:175–8  Gnanasegaran, S., Adhimoolam, M. (2022). Screening Methods for the Evaluation of Antifertility Drugs. In: Lakshmanan, M., Shewade, D.G., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore.  Haddad LB, Townsend JW, Sitruk-Ware R. Contraceptive Technologies: Looking Ahead to New Approaches to Increase Options for Family Planning. Clin Obstet Gynecol. 2021 Sep 1;64(3):435- 448.